home_banner.png
 

Gelesis is a biotechnology company developing a novel category of potential therapies for GI-related chronic diseases including obesity, NAFLD/NASH, IBD and type 2 diabetes by targeting the natural processes of the GI pathway.

Please visit http://www.gelesis.com for more information.